Mikiko Okada Selected Research

CGS 27023A

1/2008	Matrix metalloproteinase inhibitor, MMI270 (CGS27023A) inhibited hematogenic metastasis of B16 melanoma cells in both experimental and spontaneous metastasis models.
7/2003	Treatment of cold injury-induced brain edema with a nonspecific matrix metalloproteinase inhibitor MMI270 in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mikiko Okada Research Topics

Disease

2	Atopic Dermatitis (Atopic Eczema) 10/2003 - 08/2002
1	Melanoma (Melanoma, Malignant) 01/2008
1	Experimental Melanoma 01/2008
1	Neoplasm Metastasis (Metastasis) 01/2008
1	Neoplasms (Cancer) 01/2008
1	Lymphatic Metastasis 01/2008
1	Neoplasm Micrometastasis 01/2008
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2003
1	Parakeratosis 10/2003
1	Cold Injury 07/2003
1	Brain Edema (Cerebral Edema) 07/2003
1	Asthma (Bronchial Asthma) 08/2002
1	Rhinitis 08/2002
1	Erythema 08/2002
1	Hypersensitivity (Allergy) 06/2002

Drug/Important Bio-Agent (IBA)

2	Matrix Metalloproteinase InhibitorsIBA 01/2008 - 07/2003
2	CGS 27023AIBA 01/2008 - 07/2003
1	Melanins (Melanin)IBA 01/2008
1	Matrix Metalloproteinases (MMPs)IBA 01/2008
1	nile redIBA 10/2003
1	Detergents (Detergent)IBA 10/2003
1	involucrinIBA 10/2003
1	A 7 (A-7)IBA 07/2003
1	CopperIBA 07/2003
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2003
1	Evans Blue (Blue, Evans)FDA Link 07/2003
1	Hematoxylin (Haematoxylon)IBA 07/2003
1	NitrogenIBA 07/2003
1	Immunoglobulin E (IgE)IBA 08/2002
1	AllergensIBA 08/2002
1	Interleukin-5 (Interleukin 5)IBA 08/2002
1	CytokinesIBA 08/2002
1	Histamine (Histamine Dihydrochloride)FDA Link 06/2002

Therapy/Procedure

1	Lymph Node Excision (Lymph Node Dissection) 01/2008